Cargando…

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates

BACKGROUND: We tested for upgrading (Gleason grade group [GGG] ≥ 4) and/or upstaging to non‐organ‐confined stage ([NOC] ≥ pT3/pN1) in intermediate unfavorable‐risk (IU) prostate cancer (PCa) patients treated with radical prostatectomy, since both change the considerations for dose and/or type of rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorce, Gabriele, Flammia, Rocco Simone, Hoeh, Benedikt, Chierigo, Francesco, Hohenhorst, Lukas, Panunzio, Andrea, Stabile, Armando, Gandaglia, Giorgio, Tian, Zhe, Tilki, Derya, Terrone, Carlo, Gallucci, Michele, Chun, Felix K. H., Antonelli, Alessandro, Saad, Fred, Shariat, Shahrokh F., Montorsi, Francesco, Briganti, Alberto, Karakiewicz, Pierre I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325037/ https://www.ncbi.nlm.nih.gov/pubmed/35365851 http://dx.doi.org/10.1002/pros.24349

Ejemplares similares

Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy
por: Chierigo, Francesco, et al.
Publicado: (2022)

Contemporary seminal vesicle invasion rates in NCCN high‐risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

The association of the type and number of D’Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2023)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2022)

The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2023)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients
por: Tappero, Stefano, et al.
Publicado: (2022)

Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Penile rehabilitation after radical prostatectomy: does it work?
por: Gandaglia, Giorgio, et al.
Publicado: (2015)

Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Editorial: Minimally-invasive treatment for genitourinary cancers: what comes next?
por: Chierigo, Francesco, et al.
Publicado: (2023)

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021)

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Primary lymphomas of the genitourinary tract: A population-based study
por: Palumbo, Carlotta, et al.
Publicado: (2020)

Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy
por: Bandini, Marco, et al.
Publicado: (2018)

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer
por: Bravi, Carlo A., et al.
Publicado: (2022)

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations
por: Nocera, Luigi, et al.
Publicado: (2022)

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response
por: Grubmüller, Bernhard, et al.
Publicado: (2021)

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review
por: Pellegrino, Antony, et al.
Publicado: (2022)

Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation
por: Mantica, Guglielmo, et al.
Publicado: (2022)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fp8348dsuds4hc6q0603v2qreh